These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1371169)

  • 41. Immunogenicity study of a synthetic T-cell epitope of rubella virus capsid protein recognized by human T cells in different strains of mice.
    Ou D; Chong P; Gillam S
    Viral Immunol; 1994; 7(1):41-5. PubMed ID: 7986336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hepatitis nucleocapsid as a vaccine carrier moiety.
    Milich DR; Peterson DL; Zheng J; Hughes JL; Wirtz R; Schödel F
    Ann N Y Acad Sci; 1995 May; 754():187-201. PubMed ID: 7542855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.
    Ou D; Mitchell LA; Décarie D; Tingle AJ; Nepom GT
    Hum Immunol; 1998 Mar; 59(3):149-57. PubMed ID: 9548074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential of retro-inverso peptides as synthetic vaccines.
    Van Regenmortel MH; Guichard G; Benkirane N; Briand JP; Muller S; Brown F
    Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes.
    Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R
    Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.
    Reynolds SR; Dahl CE; Harn DA
    J Immunol; 1994 Jan; 152(1):193-200. PubMed ID: 7504709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles.
    Zhou J; Sun XY; Davies H; Crawford L; Park D; Frazer IH
    Virology; 1992 Aug; 189(2):592-9. PubMed ID: 1379392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.
    Lonning SM; Zhang W; McGuire TC
    J Virol; 1999 May; 73(5):4257-65. PubMed ID: 10196322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.
    Ferrari C; Bertoletti A; Penna A; Cavalli A; Valli A; Missale G; Pilli M; Fowler P; Giuberti T; Chisari FV
    J Clin Invest; 1991 Jul; 88(1):214-22. PubMed ID: 1711541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.
    Chandrachud LM; Grindlay GJ; McGarvie GM; O'Neil BW; Wagner ER; Jarrett WF; Campo MS
    Virology; 1995 Aug; 211(1):204-8. PubMed ID: 7544045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.
    Gagnon SJ; Zeng W; Kurane I; Ennis FA
    J Virol; 1996 Jan; 70(1):141-7. PubMed ID: 8523518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
    Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
    J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
    Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
    Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS
    J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping cell-mediated immunodominant domains of the rubella virus structural proteins using recombinant proteins and synthetic peptides.
    Lovett AE; McCarthy M; Wolinsky JS
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():445-52. PubMed ID: 8445367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
    Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
    Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of T- and B-cell epitopes in synthetic peptides derived from a Streptococcus mutans protein and characterization of their antigenicity and immunogenicity.
    Lehner T; Walker P; Smerdon R; Childerstone A; Bergmeier LA; Haron J
    Arch Oral Biol; 1990; 35 Suppl():39S-45S. PubMed ID: 1708230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.